EHA21 Presidential Symposium

EHA21 Presidential Symposium
June 11, 2021
Type of event: Symposium
Country: Netherlands
We are honored that the first interim results of our phase 3 ALPINE study comparing the efficacy of zanubrutinib vs ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma has been selected for the EHA21 Presidential Symposium which will take place on 11th June 2021, 16:00 – 17:30 CEST. The data will be presented by Prof. Peter Hillmen.